This HTML5 document contains 123 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n8http://dx.doi.org/10.3390/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q47101932
rdf:type
wikibase:Item
schema:description
artículu científicu 2017年學術文章 2017年學術文章 vedecký článok tudományos cikk artigo científico 2017年學術文章 naučni članak article scientifique επιστημονικό άρθρο 2017年學術文章 scientific article published on 15 December 2017 bilimsel makale articolo scientifico 2017年の論文 scienca artikolo artikulong pang-agham vetenskaplig artikel article scientific article científic 2017年学术文章 wissenschaftlicher Artikel vitskapeleg artikkel artigo científico 2017年学术文章 מאמר מדעי 2017年学术文章 2017年学术文章 научна статия научни чланак scientific article published on 15 December 2017 artikel ilmiah 2017년 논문 2017年学术文章 bài báo khoa học 2017年學術文章 tieteellinen artikkeli научни чланак videnskabelig artikel სამეცნიერო სტატია vitenskapelig artikkel artigo científico artykuł naukowy wetenschappelijk artikel vědecký článek บทความทางวิทยาศาสตร์ мақолаи илмӣ 2017 nî lūn-bûn научная статья articol științific artikull shkencor ১৫ ডিসেম্বর ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ مقالة علمية نشرت في 15 ديسمبر 2017 scientific article published on 15 December 2017 artículo científico publicado en 2017 2017年学术文章 teaduslik artikkel наукова стаття, опублікована в грудні 2017
p:P577
wds:Q47101932-F4AC66CD-EB3B-466A-AEB8-4837156F3A5A
wdt:P577
2017-12-15T00:00:00Z
p:P2860
wds:Q47101932-BDC0C4DF-3290-4B33-958D-A94EB5431F27 wds:Q47101932-D3DB6778-C73A-45D0-8690-E247EA21517A wds:Q47101932-D05D01B7-11CD-407C-B724-E5443F4DC25C wds:Q47101932-0251D519-8619-465C-8A5C-C96ADBA24A8F wds:Q47101932-1E395BCC-8452-4D3C-AD15-CAFBD5817A83 wds:Q47101932-0BED6034-A363-43E6-97F1-6E02DA2F974B wds:Q47101932-4379478A-A300-41C8-B502-3DBB9A7BE23D wds:Q47101932-4129F204-27D6-41E5-8692-39C65773F6A2 wds:Q47101932-4534EAAF-2CD3-4C15-BD18-7E809D3DE3C2 wds:Q47101932-E013CCC5-0346-47CC-A110-9FD223F6F0A9 wds:Q47101932-5CE6214C-E73D-4A9B-9642-2AD8492AADB2 wds:Q47101932-5E1F8880-A5D8-44CA-8D38-6181AD2A6408
wdt:P2860
wd:Q38693312 wd:Q41700620 wd:Q36727138 wd:Q42794690 wd:Q36205157 wd:Q48638329 wd:Q53203772 wd:Q41201314 wd:Q56770350 wd:Q37348247 wd:Q43289404 wd:Q38895092
rdfs:label
Functional Imaging with 18F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient. Functional Imaging with 18F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient.
skos:prefLabel
Functional Imaging with 18F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient. Functional Imaging with 18F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient.
schema:name
Functional Imaging with 18F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient. Functional Imaging with 18F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient.
p:P50
wds:Q47101932-57AE0C55-5995-48C8-BC66-2574A5D21BE8 wds:Q47101932-3A05C2F8-095D-49F3-8FD4-FC12B4FEC590 wds:Q47101932-ABB168D9-2B2E-41EF-B5BB-DAF83DA4D8DC wds:Q47101932-5D188147-B23B-4921-8885-848DD1310A05
wdt:P50
wd:Q41559696 wd:Q43115581 wd:Q23061917 wd:Q87871294
p:P1476
wds:Q47101932-6A1B6303-D8BA-4A4F-956F-B497D06D878F
wdt:P1476
Functional Imaging with 18F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient
p:P31
wds:Q47101932-5B40EA03-133E-4CC8-A1D9-C05310598B06
wdt:P31
wd:Q13442814
p:P921
wds:Q47101932-73E78118-FA62-40C4-998B-6801C975CCB2
wdt:P921
wd:Q422252
p:P698
wds:Q47101932-A571CE23-6EB0-46C6-B219-0200EC84C80C
wdtn:P698
n12:29244720
wdt:P698
29244720
p:P1433
wds:Q47101932-9351DF1E-2A49-4B0F-A321-4D4F53CADCB6
wdt:P1433
wd:Q27726498
p:P433
wds:Q47101932-9946A6C6-8E22-42F4-AA77-9B5E90B9BD68
p:P478
wds:Q47101932-ACE4DE6A-7389-4B0E-BB45-07A3E7598B39
wdt:P433
4
wdt:P478
7
p:P356
wds:Q47101932-20D58F26-7CE3-4389-8F1B-99DB6F966363
wdtn:P356
n8:DIAGNOSTICS7040061
wdt:P356
10.3390/DIAGNOSTICS7040061
p:P275
wds:Q47101932-88a34458-be9d-453a-bbef-766f3500e210
p:P6216
wds:Q47101932-fe278212-d123-486e-b1b9-9eff96a3ade7
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863
p:P932
wds:Q47101932-C47BAB0A-46BF-4DA0-9EBD-0D831AF8EFD6
wdt:P932
5745397